# A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

> **NCT01039428** · PHASE2 · COMPLETED · sponsor: **KDL Inc.** · enrollment: 68 (actual)

## Conditions studied

- Hyperphosphatemia
- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** HS219
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01039428
- **Lead sponsor:** KDL Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2015-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01039428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01039428, "A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01039428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*